Stocktoria
Envista Holdings Corp NVST
Envista Holdings Corp (NVST) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $2.7B at a 1.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.5 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-11 | Barclays | Overweight (main) |
| 2026-05-07 | JP Morgan | Neutral (main) |
| 2026-05-07 | Evercore ISI Group | Outperform (main) |
| 2026-05-07 | Baird | Outperform (main) |
| 2026-04-24 | Morgan Stanley | Equal-Weight (main) |
| 2026-04-15 | Citigroup | Neutral (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.207 |
| Retained earnings / assets | -0.078 |
| EBIT / assets | 0.038 |
| Equity / liabilities | 1.207 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NVST | Envista Holdings Corp | 8/9 | 2.63 | 93.3 | +8.3% |
| XRAY | DENTSPLY SIRONA Inc. | 6/9 | -0.3 | — | -3% |
| SONX | Sonendo, Inc. | 3/9 | — | — | -9% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
| HMC | HONDA MOTOR CO LTD | 6/9 | 2.79 | — | +19.9% |
| SONY | Sony Group Corp | 6/9 | 0.86 | — | +9% |
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
FAQ
Is NVST financially healthy?
Envista Holdings Corp's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does NVST pay a dividend?
No, Envista Holdings Corp does not currently pay a dividend.
How profitable is NVST?
In FY2025, Envista Holdings Corp had a net margin of 1.7% and a return on equity of 1.5%.
Is NVST overvalued or undervalued?
Envista Holdings Corp trades at about 102.5× trailing earnings — above its 10-year norm (10-year range 18.5×–177.7×, median 28.5×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for NVST?
The average Wall-Street price target for Envista Holdings Corp is $29.69, about 3.4% above the recent price, from 13 analysts.
Is NVST a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Envista Holdings Corp: a Piotroski F-score of 8/9, an Altman Z″ in the safe zone, a P/E of about 93.3×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.